Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1231257

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1231257

e-Clinical Trial Technologies

PUBLISHED:
PAGES: 204 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global e-Clinical Trial Technologies Market to Reach $27.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for e-Clinical Trial Technologies estimated at US$10.4 Billion in the year 2022, is projected to reach a revised size of US$27.7 Billion by 2030, growing at aCAGR of 13% over the period 2022-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is projected to record 13.9% CAGR and reach US$8.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electronic Data Capture (EDC) segment is readjusted to a revised 13.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 12.3% CAGR

The e-Clinical Trial Technologies market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.1% and 10.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 64 Featured):

  • BioClinica
  • Bio-Optronics
  • CRF Health
  • Datatrak International
  • e-Clinical solutions Inc.
  • ERT
  • MaxisIT
  • Medidata Solutions
  • OmniComm Systems
  • Oracle Corporation
  • PAREXEL International Corporation
Product Code: MCP-6744

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • A Prelude
    • Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial Technologies
    • Global Market Overview
    • Outsourcing of Clinical Studies to Developing Countries Benefits Market
    • Globalization Boosts e-Clinical Trials Market
    • Key Challenges for e-Clinical Trials
    • Role of Contract Research Organizations (CROs) in Clinical Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
    • e-Clinical Trial Technologies - Global Key Competitors Percentage Market Share in 2021 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Global Population Offers Increased Growth Opportunities
    • Pharmaceutical Firms and CROs to Drive Adoption Rate
    • Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies Demand
    • CROs - The Targeted Customers for e-Clinical Trial Technologies
    • Increased Importance of e-Clinical Integration
    • Big Data and Patient Centricity: Areas to Increase Focus Upon
    • Esource Documentation Witnesses Increased Traction
    • Increased Adoption of electronic Trial Master File (eTMFs)
    • Risk-Based Monitoring Witnesses New Modifications
    • Growing Implementation of e-Consent
    • Increased Investments in Virtual Clinical Trials
    • Open Source - Emerging Solutions in Clinical Trials Domain
    • Mobile Technologies to Help Trial Operators in Tackling Challenges
    • Smartphones & Tablets: The New Age ePRO Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for EDC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for EDC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for EDC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RTSM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RTSM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for RTSM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for ePROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for ePROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for ePROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Electronic Data Capture (EDC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Electronic Data Capture (EDC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Electronic Data Capture (EDC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Electronic Clinical Outcome Assessment (eCOA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Electronic Clinical Outcome Assessment (eCOA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Electronic Clinical Outcome Assessment (eCOA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Randomization & Trial Supply Management (RTSM) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Randomization & Trial Supply Management (RTSM) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Randomization & Trial Supply Management (RTSM) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Clinical Analytics Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Clinical Analytics Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Clinical Analytics Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Electronic Trial Master File (eTMF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Electronic Trial Master File (eTMF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Electronic Trial Master File (eTMF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Clinical Data Integration Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Clinical Data Integration Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Clinical Data Integration Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Safety Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Safety Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Safety Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Web-Hosted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Web-Hosted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Web-Hosted by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Licensed Enterprise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Licensed Enterprise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 45: World 16-Year Perspective for Licensed Enterprise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 48: World 16-Year Perspective for Phase I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 49: World Recent Past, Current & Future Analysis for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 50: World Historic Review for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 51: World 16-Year Perspective for Phase II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 52: World Recent Past, Current & Future Analysis for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 53: World Historic Review for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 54: World 16-Year Perspective for Phase III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 55: World Recent Past, Current & Future Analysis for Phase IV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 56: World Historic Review for Phase IV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 57: World 16-Year Perspective for Phase IV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 58: World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 59: World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 60: World 16-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 61: World Recent Past, Current & Future Analysis for Hospitals / Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 62: World Historic Review for Hospitals / Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 63: World 16-Year Perspective for Hospitals / Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 64: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 65: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 66: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 67: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 68: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 69: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 70: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 71: World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 72: World 16-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 73: World e-Clinical Trial Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 74: World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 75: World Historic Review for e-Clinical Trial Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: World 16-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 77: USA Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: USA 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 80: USA Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: USA Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: USA 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 83: USA Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: USA Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: USA 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 86: USA Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: USA Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: USA 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 89: USA Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: USA Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: USA 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 92: Canada Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Canada Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Canada 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 95: Canada Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Canada Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Canada 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 98: Canada Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Canada Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Canada 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 101: Canada Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Canada Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Canada 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 104: Canada Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Canada Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Canada 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • JAPAN
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 107: Japan Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Japan Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Japan 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 110: Japan Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Japan Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Japan 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 113: Japan Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Japan Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Japan 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 116: Japan Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Japan Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Japan 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 119: Japan Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Japan Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Japan 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • CHINA
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 122: China Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: China Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: China 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 125: China Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: China Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: China 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 128: China Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: China Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: China 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 131: China Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: China Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: China 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 134: China Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: China Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: China 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • EUROPE
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 137: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Europe Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Europe 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 140: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Europe Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Europe 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 143: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Europe Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Europe 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 146: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Europe Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Europe 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 149: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Europe Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Europe 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
    • TABLE 152: Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 153: Europe Historic Review for e-Clinical Trial Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Europe 16-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 155: France Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: France Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: France 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 158: France Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: France Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: France 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 161: France Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: France Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: France 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 164: France Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: France Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: France 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 167: France Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: France Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: France 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • GERMANY
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 170: Germany Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Germany Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Germany 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 173: Germany Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Germany Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Germany 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 176: Germany Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Germany Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Germany 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 179: Germany Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Germany Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Germany 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 182: Germany Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Germany Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Germany 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 185: Italy Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Italy Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Italy 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 188: Italy Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Italy Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Italy 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 191: Italy Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Italy Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Italy 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 194: Italy Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Italy Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Italy 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 197: Italy Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Italy Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Italy 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 200: UK Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: UK Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: UK 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 203: UK Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: UK Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: UK 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 206: UK Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: UK Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: UK 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 209: UK Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: UK Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: UK 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 212: UK Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: UK Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: UK 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 215: Rest of Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Rest of Europe Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Rest of Europe 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 218: Rest of Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Rest of Europe Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Rest of Europe 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Rest of Europe Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Rest of Europe 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Rest of Europe 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Europe Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Rest of Europe 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • e-Clinical Trial Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 230: Asia-Pacific Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Asia-Pacific Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Asia-Pacific 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 233: Asia-Pacific Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Asia-Pacific Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Asia-Pacific 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Asia-Pacific Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Asia-Pacific 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Asia-Pacific 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Asia-Pacific 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 245: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Rest of World Historic Review for e-Clinical Trial Technologies by Application - EDC, RTSM, CTMS and ePROs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Rest of World 16-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Value Sales for EDC, RTSM, CTMS and ePROs for the Years 2014, 2023 & 2030
    • TABLE 248: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Rest of World Historic Review for e-Clinical Trial Technologies by Product - Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Rest of World 16-Year Perspective for e-Clinical Trial Technologies by Product - Percentage Breakdown of Value Sales for Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA), Randomization & Trial Supply Management (RTSM), Clinical Analytics Platforms, Electronic Trial Master File (eTMF), Clinical Data Integration Platforms and Safety Solutions for the Years 2014, 2023 & 2030
    • TABLE 251: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Rest of World Historic Review for e-Clinical Trial Technologies by Delivery mode - Web-Hosted, Cloud and Licensed Enterprise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Rest of World 16-Year Perspective for e-Clinical Trial Technologies by Delivery mode - Percentage Breakdown of Value Sales for Web-Hosted, Cloud and Licensed Enterprise for the Years 2014, 2023 & 2030
    • TABLE 254: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Rest of World Historic Review for e-Clinical Trial Technologies by Development Phase - Phase I, Phase II, Phase III and Phase IV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Rest of World 16-Year Perspective for e-Clinical Trial Technologies by Development Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Phase IV for the Years 2014, 2023 & 2030
    • TABLE 257: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Rest of World Historic Review for e-Clinical Trial Technologies by End-Use - CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Rest of World 16-Year Perspective for e-Clinical Trial Technologies by End-Use - Percentage Breakdown of Value Sales for CROs, Hospitals / Healthcare Providers, Pharma & Biotech Companies, Academic Institutes and Medical Device Manufacturers for the Years 2014, 2023 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!